A Cross-Sectional Study of How to Manage Polycystic Ovarian Syndrome among Infertile Women in Al Jabal Al Akhdar, Albayda , Libya
Main Article Content
Abstract
Polycystic ovary syndrome (PCOS) affects 5–18% of women, and is a reproductive, metabolic, and psychological condition with impacts across the lifespan. The cause is complex, and includes genetic and epigenetic susceptibility, hypothalamic and ovarian dysfunction, excess androgen exposure, insulin resistance, and adiposity-related mechanisms(1). This study aims to highlight the ages that are susceptible to developing polycystic ovary syndrome, identify diagnosis methods used in the Al bayda fertility center. At the same time the study aims to evaluate treatment choices which are used to manage PCOS in patients at the center. Out of 107 patients, about of 36 studied patient who had PCOS fell in the 26-30 age range, this was followed by patients whose ages bracket was 20-25 years old (n=30/107). A high percentage of patients whose age from 31-35 years old was recorded (n=27/107) in the current study the main diagnosis method used in the center is hormonal assay, followed by ultrasound and hysteroscopy with 97%, 74.30% and 20.95%respectively.according to our research the most treatment used for PCOS is metformin followed by celine with 80% and 65.71% respectively. Another high proportion were recorded for folic acid, vitamin D, weight loss and food supplement with approximately equal proportion(40%). according to this research the number of patient who got pregnancy after treatment was 31, while the number of those who did not get pregnant reached to 22 and the rest of them stopped follow up at the center, that the best chances of pregnancy were recorded for the age group from 26 to 30 at a rate of 41.9%, followed by the age group from 31 to 35 (25.8%), while the lowest percentage was for the age group from 36-40 (9.7%). Finally, there were no chances of conceiving for the age group from 41. Up to 45 (0%)